12:00 AM
 | 
May 21, 2012
 |  BC Week In Review  |  Company News  |  Other News

Merck KGaA pharmaceuticals news

Merck hopes to achieve €300 million ($386.6 million) in net cost savings by 2014 through the previously announced restructuring of its Merck Serono biotech division. The target follows last month's news that the pharma will shutter Merck Serono's headquarters in Geneva, Switzerland, and eliminate 500 (40%) of the...

Read the full 216 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >